awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q58740200-062A40AF-905C-4F2E-8CB3-AF50884FD453
Q58740200-062A40AF-905C-4F2E-8CB3-AF50884FD453
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58740200-062A40AF-905C-4F2E-8CB3-AF50884FD453
New strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1
P2860
Q58740200-062A40AF-905C-4F2E-8CB3-AF50884FD453
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58740200-062A40AF-905C-4F2E-8CB3-AF50884FD453
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7d0fee9bdae2f5589d40c0be317542c2d5af39c1
P2860
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.